ScholarIQanswers from OpenAlex & ORCID
Gerardo Rosati
ResearcherPublications, citations & collaboration network
Gerardo Rosati is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gerardo Rosati have?
ScholarIQindexed works
Gerardo Rosati has 216 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gerardo Rosati have?
ScholarIQcitation count
Gerardo Rosati has 3,812 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gerardo Rosati?
ScholarIQh-index
Gerardo Rosati has an h-index of 32 in OpenAlex.
What is the i10-index of Gerardo Rosati?
ScholarIQi10-index
Gerardo Rosati has an i10-index of 75 in OpenAlex.
What is the ORCID of Gerardo Rosati?
ScholarIQorcid
The ORCID for Gerardo Rosati is on the source record.
What is the OpenAlex record for Gerardo Rosati?
ScholarIQopenalex
The OpenAlex for Gerardo Rosati is on the source record.
What are the most-cited papers on Gerardo Rosati?
ScholarIQmost cited works
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
C. Aschele, L. Cionini, Sara Lonardi, Carmine Pinto, Stefano Cordio, Gerardo Rosati, Salvatore Artale, A. Tagliagambe, Giovanni Ambrosini, Paola Rosetti, Andrea Bonetti, Maria Emanuela Negru, Maria Chiara Tronconi, Gabriele Luppi, Giovanni Silvano, Domenico Corsi, Anna Maria Bochicchio, Germana Chiaulon, Maurizio Gallo, Luca Boni
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
Gerardo Rosati, G. Ambrosini, Sandro Barni, B. Andreoni, G Corradini, Giovanna Luchena, Bruno Daniele, Fernando Gaion, Giovanni William Oliverio, Mary Duro, G. Martignoni, N. Pinna, Pietro Sozzi, G. Pancera, Gaspare Solina, Gianfranco Pavia, Sandro Pignata, F. Bing Johnson, Roberto Labianca, Giovanni Apolone, Alberto Zaniboni, Marta Monteforte, Eva Negri, Valter Torri, Paola Mosconi, Roldano Fossati
Lapatinib in breast cancer
Domenico Bilancia, Gerardo Rosati, Angelo Dinota, Domenico Germano, Rosangela Romano, Luigi Manzione
Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial
C. Aschele, Carmine Pinto, Stefano Cordio, Gerardo Rosati, A. Tagliagambe, Salvatore Artale, Paola Rosetti, Sara Lonardi, Luca Boni, L. Cionini, on behalf of STAR Network Investigators
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang‐Shu Ou, Jeffrey P. Meyers, Qian Shi, Axel Grothey, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Holländer, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul